Skip to content

Study on sequential renal replacement therapy for elderly critical patients in ICU

Study on sequential renal replacement therapy for elderly critical patients in ICU

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039211
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-30
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemopurification

Interventions

CVVHD group:CVVHD
CVVH group:CVVH
CVVHDF:CVVHDF

Sponsors

Changzhou hospital of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 97 Years

Inclusion criteria

Inclusion criteria: All patients over 65 years old met the CRRT initiation criteria specified in the guidelines for the application of blood purification in ICU issued by the society of critical care medicine of Chinese Medical Association in 2012 1. Patients with acute renal failure or exacerbation of chronic renal failure: non obstructive oliguria (urine volume 30mmol / L) with urine volume 6.5 mmol / L) or rapid increase of blood potassium, diuresis, calcium gluconate, high glucose insulin can not be corrected; severe sodium ion disorders (blood Na + > 160 mmol / L or 39.5 degree C); 4. Patients with refractory heart failure and ineffective drug treatment; 5. Patients with pathological coagulation disorder and ineffective drug treatment; If one of the above criteria is met, CRRT can be started, and if two criteria are met, CRRT must be started.

Exclusion criteria

Exclusion criteria: Patients with advanced stage of tumor affecting the outcome of the disease or patients with severe liver failure or immune system diseases need plasma exchange.

Design outcomes

Primary

MeasureTime frame
Inflammatory mediator;lymphocyte;blood transfusion;mortality;

Secondary

MeasureTime frame
treatment expense;

Countries

China

Contacts

Public ContactMa Haiying

Changzhou Hospital of Traditional Chinese Medicine

haiying_mahh@163.com+86 13701599325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026